On Tuesday, JPMorgan revised its stance on Unum Group (NYSE:) stock, downgrading the rating from Overweight to Neutral. Despite the downgrade, the firm increased its price target for Unum shares from $74.00 to $79.00.
The adjustment by JPMorgan reflects a mix of recognition for Unum’s strong performance in its core business areas and a reassessment of investor sentiment towards the company’s stock valuation.
According to InvestingPro data, Unum has demonstrated remarkable strength with a 64.6% return over the past year and maintains a “GREAT” financial health score of 3.24 out of 4. Current analysis suggests the stock is trading near its Fair Value.
JPMorgan acknowledges Unum’s robust group benefits franchise and anticipates continued strength in the company’s core business, characterized by solid disability margins and growth across most business lines. The favorable labor market, along with the lag effect of high inflation and the prevalence of work-from-home arrangements, are expected to support strong near-term disability margins.
These factors are projected to contribute to potential increases in earnings, free cash flow, and share repurchases for Unum. InvestingPro data reveals the company’s strong financial foundation, with a healthy current ratio of 17.61 and an impressive track record of raising dividends for 16 consecutive years.
However, concerns persist regarding Unum’s exposure to long-term care (LTC) insurance. Despite these apprehensions, JPMorgan believes that the probability of significant reserve additions in the short term is low, following a sizeable charge taken in the third quarter of 2023. This view is underpinned by the sentiment that the likelihood of a major reserve addition has lessened, and the focus has shifted towards the prospect of a de-risking transaction.
JPMorgan expressed skepticism about the market’s optimism surrounding a potential de-risking deal for Unum’s LTC obligations. The firm noted that investors seem to be overestimating the likelihood of such a transaction, which has been speculated for years without materializing. Additionally, the firm pointed out that even with two transactions since late 2023, Manulife Financial Corporation (NYSE:) has only managed to divest 16% of its LTC block, indicating that the fundamental exposure to LTC has decreased less than it appears.
The revised price target suggests that JPMorgan sees some upside potential for Unum’s stock, but the downgrade to a Neutral rating implies a more cautious outlook on the stock’s prospects compared to the previous Overweight rating. Trading at a P/E ratio of 7.95 and with a market capitalization of $13.38 billion, Unum presents an interesting case for investors.
For a deeper understanding of Unum’s valuation and prospects, InvestingPro subscribers can access the comprehensive Pro Research Report, which includes detailed analysis and additional metrics among the platform’s extensive features.
In other recent news, Unum Group has been the subject of positive analyst attention. Piper Sandler reaffirmed its Overweight rating on Unum Group, citing affirmations of long-term care assumptions, favorable claims trends, and technological advancements as key reasons. The firm’s analysts also noted the insurance company’s proactive approach to business development, as indicated by discussions with potential partners.
Unum Group recently reported strong Q3 2024 financial results, with adjusted earnings per share (EPS) reaching $2.13 and statutory earnings exceeding $300 million for the quarter. This robust performance has brought the company’s total earnings to over $1 billion year-to-date. Analysts project that Unum Group will achieve an EPS growth between 10% and 15% for the year, surpassing initial expectations.
The company also announced a share repurchase plan set at approximately $1 billion for 2024. Despite a decrease in sales, particularly in Group Disability, Unum Group’s premium growth in core operations stood at 4.6% for the quarter. These recent developments highlight Unum Group’s strong balance sheet with $1.4 billion in liquidity and a 12.5% return on equity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
